56 46 42 35 28 21 14 7 Day Group 26.000 ± 1.40 28.722 ± 1.92 27.730 ± 2.63 24.743±2.30 24.610±2.39 24.022±2.81 22.386±1.68 22.360 ± 1.62 C 34.808 ± 2.61 33.668 ± 1.65 30.670 ± 0.94 25.990 ± 1.40 19.433 ± 0.40 16.237 ± 0.16 14.820 ± 0.83 13.935 ± 1.46 L1 28.700 ± 2.87 25.786 ± 1.25 23.757 ± 1.59 21.253 ± 0.53 19.799 ± 0.14 12.936 ± 0.75 11.975 ± 0.02 11.906 ± 0.07 L2 25.000 ± 0.70 22.859 ± 2.01 21.782 ± 0.15 21.606 ± 0.28 19.039 ± 0.68 16.846 ± 0.59 15.848 ± 0.11 13.936 ± 1.46 L3 25.750 ± 1.23 24.750 ± 2.25 22.642 ± 1.86 18.917 ± 0.77 18.637 ± 0.96 15.836 ± 0.12 11.875 ± 0.09 11.768 ± 0.16 L4

Table 8: Percentages blood heterophils in experimental and control groups (%).